These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2771996

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. When is a cystectomy necessary in carcinoma in situ?
    Herr HW.
    Prog Clin Biol Res; 1989; 303():511-5. PubMed ID: 2780659
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
    Debruyne FM, van der Meijden AP, Schreinemachers LM, Geboers AD, Franssen MP, van Leeuwen MJ, Steerenberg PA, de Jong WH, Ruitenberg EJ.
    Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662
    [No Abstract] [Full Text] [Related]

  • 5. Immunopathological effects of intravesical BCG therapy.
    Prescott S, James K, Hargreave TB, Chisholm GD, Smyth JF.
    Prog Clin Biol Res; 1989; 310():93-105. PubMed ID: 2672025
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravesical Bacillus Calmette Guerin therapy in patients with superficial bladder tumor.
    Steg A, Belas M, Leleu C, Boccon-Gibod L.
    Prog Clin Biol Res; 1989; 303():375-81. PubMed ID: 2780654
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Percutaneous, oral, or intravesical BCG administration: what is the optimal route?
    Lamm DL, Sarodosy MS, DeHaven JI.
    Prog Clin Biol Res; 1989; 310():301-10. PubMed ID: 2672018
    [No Abstract] [Full Text] [Related]

  • 11. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
    Jakse G.
    Wien Klin Wochenschr; 1987 Feb 20; 99(4):114-8. PubMed ID: 3577186
    [Abstract] [Full Text] [Related]

  • 12. Intravesical BCG therapy in patients with superficial bladder tumors.
    Steg A, Belas M, Leleu C, Boccon-Gibod L.
    Prog Clin Biol Res; 1989 Feb 20; 310():153-60. PubMed ID: 2771990
    [No Abstract] [Full Text] [Related]

  • 13. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Nov 20; 50(11):767-71. PubMed ID: 15628536
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M.
    Duodecim; 2002 Nov 20; 118(9):903-9. PubMed ID: 12238168
    [No Abstract] [Full Text] [Related]

  • 17. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB.
    Semin Urol Oncol; 2000 Nov 20; 18(4):280-8. PubMed ID: 11101091
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
    Nishino Y, Yasuda M, Yokoi S, Ehara H, Yamamoto N, Takahashi Y, Ishihara S, Deguchi T, Kawada Y, Takeda A, Sakai S, Takeuchi T, Taniguchi M, Minoshima K, Hamamoto Y, Kanimoto Y, Nakano M, Fujihiro S, Nezasa S, Matsuda T, Nagatani Y, Maeda S, Tamaki M, Saito A, Komeda H.
    Gan To Kagaku Ryoho; 1999 Oct 20; 26(12):1869-73. PubMed ID: 10560414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.